Aurinia Pharmaceuticals
AUPH
11 hedge funds and large institutions have $19.3M invested in Aurinia Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$9.05M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$8.8M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$2.59M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$474K |
| 5 |
CCMU
Cheyne Capital Management (UK)
London,
United Kingdom
|
+$380K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NMC
1
NEA Management Company
Timonium,
Maryland
| $8.15M | +$9.05M | +2,546,843 | New |
|
|
GPP
2
Great Point Partners
Greenwich,
Connecticut
| $7.92M | +$8.8M | +2,474,076 | New |
|
|
BBA
3
Baker Bros. Advisors
New York
| $2.34M | +$2.59M | +727,669 | New |
|
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $426K | +$474K | +133,333 | New |
|
|
CCMU
5
Cheyne Capital Management (UK)
London,
United Kingdom
| $347K | +$380K | +106,805 | New |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $43K | +$47.8K | +13,451 | New |
|
7
Bank of Montreal
Toronto,
Ontario, Canada
| $40K | +$44.4K | +12,500 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $5K | +$5.69K | +1,600 | New |
|
|
GSC
9
Ground Swell Capital
Folly Beach,
South Carolina
| $2K | +$1.78K | +500 | New |
|
|
U
10
UBS
Zurich,
Switzerland
| – | +$142 | +40 | New |
|
11
Morgan Stanley
New York
| – | +$188 | +53 | New |
|
AUPH Hedge Fund Activity: Q3 2014 in Review
11 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q3 2014, worth a combined $19.3M.
Buyers outnumbered sellers: 11 funds opened new AUPH positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was NEA Management Company, opening a new position worth an estimated $9.05M.
- 11 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q3 2014, up from 0 in Q2 2014.
- Funds reported $19.3M of Aurinia Pharmaceuticals stock for Q3 2014.
- 11 funds opened new Aurinia Pharmaceuticals positions in Q3 2014 and 0 closed out, a net change of +11 holders.
- The largest Aurinia Pharmaceuticals buyer in Q3 2014 was NEA Management Company, an estimated $9.05M added.
Based on aggregated 13F filings for Q3 2014.